Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer nomograms: an update.

Felix K-H Chun1, Pierre I Karakiewicz, Alberto Briganti

  • 1Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada.

European Urology
|August 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.

Urologic oncology·2017
Same author

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer.

Urology case reports·2017
Same author

Diagnostic Accuracy of <sup>64</sup>Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience.

Urology·2017
Same author

The Microbiome of the Prostate Tumor Microenvironment.

European urology·2017
Same author

Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.

Urologic oncology·2017
Same author

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.

Clinical genitourinary cancer·2017

Updated nomograms are available for predicting prostate cancer (PCa) outcomes. These tools are valuable for assessing PCa recurrence, metastases, and survival when developed with rigorous criteria.

Area of Science:

  • Urology
  • Oncology
  • Medical Statistics

Background:

  • Prognostic nomograms are crucial for predicting outcomes in prostate cancer (PCa).
  • Numerous nomograms exist, but their development and validation vary.

Purpose of the Study:

  • To compare existing prostate cancer nomograms.
  • To identify current trends and needs in PCa nomogram development.

Main Methods:

  • Descriptive and analytic comparison of recent PCa nomograms.
  • Evaluation of predictor variables, patient cohorts, and nomogram features.
  • Assessment of accuracy estimates and validation types.

Main Results:

  • A growing number of nomograms predict key PCa endpoints like PSA recurrence, metastases, and survival.

Related Experiment Videos

  • There is a need for updated nomograms in specific areas of PCa outcome prediction.

    • Conclusions:

    • Nomograms are available for many prostate cancer outcomes.
    • They serve as valid prognostic tools when developed and validated appropriately.